0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CMO & CDMO Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-17Y1160
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global CMO CDMO Market Insights Forecast to 2028
BUY CHAPTERS

Global CMO & CDMO Market Insights, Forecast to 2030

Code: QYRE-Auto-17Y1160
Report
December 2024
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

CMO & CDMO Market

At a time when pharmaceutical companies face increasing price pressures around the globe from key payers, including public and government insurance systems, reducing operational expenses is a major driver of outsourcing pharmaceutical manufacturing to CDMOs. Also, an increasing number of pharmaceutical companies are refocusing on their core capabilities and strengths, leading to divestments of in-house manufacturing capacities in some areas and to a gro
Market Analysis and Insights: Global CMO & CDMO Market
The global CMO & CDMO market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for CMO & CDMO is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for CMO & CDMO is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for CMO & CDMO is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of CMO & CDMO include Recipharm, AMRI3, Patheon, Aenova, Catalent, Amatsigroup, WuXi PharmaTech, Strides Shasun and Piramal, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
CMO & CDMO is widely used in various fields, such as Pharmaceutical Industry, Biotechnology and Other,, etc. Pharmaceutical Industry provides greatest supports to the CMO & CDMO industry development. In 2023, global % revenue of CMO & CDMO went into Pharmaceutical Industry filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for CMO & CDMO market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of CMO & CDMO, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for CMO & CDMO, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the CMO & CDMO revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global CMO & CDMO market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for CMO & CDMO revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of CMO & CDMO Market Report

Report Metric Details
Report Name CMO & CDMO Market
Segment by Type
  • Development
  • API production
  • Formulation
Segment by Application
  • Pharmaceutical Industry
  • Biotechnology
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Recipharm, AMRI3, Patheon, Aenova, Catalent, Amatsigroup, WuXi PharmaTech, Strides Shasun, Piramal, Siegfried
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of CMO & CDMO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of CMO & CDMO companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CMO & CDMO revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the CMO & CDMO Market report?

Ans: The main players in the CMO & CDMO Market are Recipharm, AMRI3, Patheon, Aenova, Catalent, Amatsigroup, WuXi PharmaTech, Strides Shasun, Piramal, Siegfried

What are the Application segmentation covered in the CMO & CDMO Market report?

Ans: The Applications covered in the CMO & CDMO Market report are Pharmaceutical Industry, Biotechnology, Other

What are the Type segmentation covered in the CMO & CDMO Market report?

Ans: The Types covered in the CMO & CDMO Market report are Development, API production, Formulation

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CMO & CDMO Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Development
1.2.3 API production
1.2.4 Formulation
1.3 Market by Application
1.3.1 Global CMO & CDMO Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Industry
1.3.3 Biotechnology
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CMO & CDMO Market Perspective (2019-2030)
2.2 Global CMO & CDMO Growth Trends by Region
2.2.1 CMO & CDMO Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CMO & CDMO Historic Market Size by Region (2019-2024)
2.2.3 CMO & CDMO Forecasted Market Size by Region (2025-2030)
2.3 CMO & CDMO Market Dynamics
2.3.1 CMO & CDMO Industry Trends
2.3.2 CMO & CDMO Market Drivers
2.3.3 CMO & CDMO Market Challenges
2.3.4 CMO & CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue CMO & CDMO by Players
3.1.1 Global CMO & CDMO Revenue by Players (2019-2024)
3.1.2 Global CMO & CDMO Revenue Market Share by Players (2019-2024)
3.2 Global CMO & CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of CMO & CDMO, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global CMO & CDMO Market Concentration Ratio
3.4.1 Global CMO & CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CMO & CDMO Revenue in 2023
3.5 Global Key Players of CMO & CDMO Head office and Area Served
3.6 Global Key Players of CMO & CDMO, Product and Application
3.7 Global Key Players of CMO & CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CMO & CDMO Breakdown Data by Type
4.1 Global CMO & CDMO Historic Market Size by Type (2019-2024)
4.2 Global CMO & CDMO Forecasted Market Size by Type (2025-2030)
5 CMO & CDMO Breakdown Data by Application
5.1 Global CMO & CDMO Historic Market Size by Application (2019-2024)
5.2 Global CMO & CDMO Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CMO & CDMO Market Size (2019-2030)
6.2 North America CMO & CDMO Market Size by Type
6.2.1 North America CMO & CDMO Market Size by Type (2019-2024)
6.2.2 North America CMO & CDMO Market Size by Type (2025-2030)
6.2.3 North America CMO & CDMO Market Share by Type (2019-2030)
6.3 North America CMO & CDMO Market Size by Application
6.3.1 North America CMO & CDMO Market Size by Application (2019-2024)
6.3.2 North America CMO & CDMO Market Size by Application (2025-2030)
6.3.3 North America CMO & CDMO Market Share by Application (2019-2030)
6.4 North America CMO & CDMO Market Size by Country
6.4.1 North America CMO & CDMO Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America CMO & CDMO Market Size by Country (2019-2024)
6.4.3 North America CMO & CDMO Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe CMO & CDMO Market Size (2019-2030)
7.2 Europe CMO & CDMO Market Size by Type
7.2.1 Europe CMO & CDMO Market Size by Type (2019-2024)
7.2.2 Europe CMO & CDMO Market Size by Type (2025-2030)
7.2.3 Europe CMO & CDMO Market Share by Type (2019-2030)
7.3 Europe CMO & CDMO Market Size by Application
7.3.1 Europe CMO & CDMO Market Size by Application (2019-2024)
7.3.2 Europe CMO & CDMO Market Size by Application (2025-2030)
7.3.3 Europe CMO & CDMO Market Share by Application (2019-2030)
7.4 Europe CMO & CDMO Market Size by Country
7.4.1 Europe CMO & CDMO Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe CMO & CDMO Market Size by Country (2019-2024)
7.4.3 Europe CMO & CDMO Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China CMO & CDMO Market Size (2019-2030)
8.2 China CMO & CDMO Market Size by Type
8.2.1 China CMO & CDMO Market Size by Type (2019-2024)
8.2.2 China CMO & CDMO Market Size by Type (2025-2030)
8.2.3 China CMO & CDMO Market Share by Type (2019-2030)
8.3 China CMO & CDMO Market Size by Application
8.3.1 China CMO & CDMO Market Size by Application (2019-2024)
8.3.2 China CMO & CDMO Market Size by Application (2025-2030)
8.3.3 China CMO & CDMO Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia CMO & CDMO Market Size (2019-2030)
9.2 Asia CMO & CDMO Market Size by Type
9.2.1 Asia CMO & CDMO Market Size by Type (2019-2024)
9.2.2 Asia CMO & CDMO Market Size by Type (2025-2030)
9.2.3 Asia CMO & CDMO Market Share by Type (2019-2030)
9.3 Asia CMO & CDMO Market Size by Application
9.3.1 Asia CMO & CDMO Market Size by Application (2019-2024)
9.3.2 Asia CMO & CDMO Market Size by Application (2025-2030)
9.3.3 Asia CMO & CDMO Market Share by Application (2019-2030)
9.4 Asia CMO & CDMO Market Size by Region
9.4.1 Asia CMO & CDMO Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia CMO & CDMO Market Size by Region (2019-2024)
9.4.3 Asia CMO & CDMO Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America CMO & CDMO Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America CMO & CDMO Market Size by Type
10.2.1 Middle East, Africa, and Latin America CMO & CDMO Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America CMO & CDMO Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America CMO & CDMO Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America CMO & CDMO Market Size by Application
10.3.1 Middle East, Africa, and Latin America CMO & CDMO Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America CMO & CDMO Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America CMO & CDMO Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America CMO & CDMO Market Size by Country
10.4.1 Middle East, Africa, and Latin America CMO & CDMO Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America CMO & CDMO Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America CMO & CDMO Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Recipharm
11.1.1 Recipharm Company Details
11.1.2 Recipharm Business Overview
11.1.3 Recipharm CMO & CDMO Introduction
11.1.4 Recipharm Revenue in CMO & CDMO Business (2019-2024)
11.1.5 Recipharm Recent Developments
11.2 AMRI3
11.2.1 AMRI3 Company Details
11.2.2 AMRI3 Business Overview
11.2.3 AMRI3 CMO & CDMO Introduction
11.2.4 AMRI3 Revenue in CMO & CDMO Business (2019-2024)
11.2.5 AMRI3 Recent Developments
11.3 Patheon
11.3.1 Patheon Company Details
11.3.2 Patheon Business Overview
11.3.3 Patheon CMO & CDMO Introduction
11.3.4 Patheon Revenue in CMO & CDMO Business (2019-2024)
11.3.5 Patheon Recent Developments
11.4 Aenova
11.4.1 Aenova Company Details
11.4.2 Aenova Business Overview
11.4.3 Aenova CMO & CDMO Introduction
11.4.4 Aenova Revenue in CMO & CDMO Business (2019-2024)
11.4.5 Aenova Recent Developments
11.5 Catalent
11.5.1 Catalent Company Details
11.5.2 Catalent Business Overview
11.5.3 Catalent CMO & CDMO Introduction
11.5.4 Catalent Revenue in CMO & CDMO Business (2019-2024)
11.5.5 Catalent Recent Developments
11.6 Amatsigroup
11.6.1 Amatsigroup Company Details
11.6.2 Amatsigroup Business Overview
11.6.3 Amatsigroup CMO & CDMO Introduction
11.6.4 Amatsigroup Revenue in CMO & CDMO Business (2019-2024)
11.6.5 Amatsigroup Recent Developments
11.7 WuXi PharmaTech
11.7.1 WuXi PharmaTech Company Details
11.7.2 WuXi PharmaTech Business Overview
11.7.3 WuXi PharmaTech CMO & CDMO Introduction
11.7.4 WuXi PharmaTech Revenue in CMO & CDMO Business (2019-2024)
11.7.5 WuXi PharmaTech Recent Developments
11.8 Strides Shasun
11.8.1 Strides Shasun Company Details
11.8.2 Strides Shasun Business Overview
11.8.3 Strides Shasun CMO & CDMO Introduction
11.8.4 Strides Shasun Revenue in CMO & CDMO Business (2019-2024)
11.8.5 Strides Shasun Recent Developments
11.9 Piramal
11.9.1 Piramal Company Details
11.9.2 Piramal Business Overview
11.9.3 Piramal CMO & CDMO Introduction
11.9.4 Piramal Revenue in CMO & CDMO Business (2019-2024)
11.9.5 Piramal Recent Developments
11.10 Siegfried
11.10.1 Siegfried Company Details
11.10.2 Siegfried Business Overview
11.10.3 Siegfried CMO & CDMO Introduction
11.10.4 Siegfried Revenue in CMO & CDMO Business (2019-2024)
11.10.5 Siegfried Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global CMO & CDMO Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Development
    Table 3. Key Players of API production
    Table 4. Key Players of Formulation
    Table 5. Global CMO & CDMO Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global CMO & CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global CMO & CDMO Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global CMO & CDMO Market Share by Region (2019-2024)
    Table 9. Global CMO & CDMO Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global CMO & CDMO Market Share by Region (2025-2030)
    Table 11. CMO & CDMO Market Trends
    Table 12. CMO & CDMO Market Drivers
    Table 13. CMO & CDMO Market Challenges
    Table 14. CMO & CDMO Market Restraints
    Table 15. Global CMO & CDMO Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global CMO & CDMO Revenue Share by Players (2019-2024)
    Table 17. Global Top CMO & CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CMO & CDMO as of 2023)
    Table 18. Global CMO & CDMO Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by CMO & CDMO Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of CMO & CDMO, Headquarters and Area Served
    Table 21. Global Key Players of CMO & CDMO, Product and Application
    Table 22. Global Key Players of CMO & CDMO, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global CMO & CDMO Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global CMO & CDMO Revenue Market Share by Type (2019-2024)
    Table 26. Global CMO & CDMO Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global CMO & CDMO Revenue Market Share by Type (2025-2030)
    Table 28. Global CMO & CDMO Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global CMO & CDMO Revenue Share by Application (2019-2024)
    Table 30. Global CMO & CDMO Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global CMO & CDMO Revenue Share by Application (2025-2030)
    Table 32. North America CMO & CDMO Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America CMO & CDMO Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America CMO & CDMO Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America CMO & CDMO Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America CMO & CDMO Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America CMO & CDMO Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America CMO & CDMO Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe CMO & CDMO Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe CMO & CDMO Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe CMO & CDMO Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe CMO & CDMO Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe CMO & CDMO Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe CMO & CDMO Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe CMO & CDMO Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China CMO & CDMO Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China CMO & CDMO Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China CMO & CDMO Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China CMO & CDMO Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia CMO & CDMO Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia CMO & CDMO Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia CMO & CDMO Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia CMO & CDMO Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia CMO & CDMO Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia CMO & CDMO Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia CMO & CDMO Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America CMO & CDMO Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America CMO & CDMO Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America CMO & CDMO Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America CMO & CDMO Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America CMO & CDMO Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America CMO & CDMO Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America CMO & CDMO Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Recipharm Company Details
    Table 65. Recipharm Business Overview
    Table 66. Recipharm CMO & CDMO Product
    Table 67. Recipharm Revenue in CMO & CDMO Business (2019-2024) & (US$ Million)
    Table 68. Recipharm Recent Developments
    Table 69. AMRI3 Company Details
    Table 70. AMRI3 Business Overview
    Table 71. AMRI3 CMO & CDMO Product
    Table 72. AMRI3 Revenue in CMO & CDMO Business (2019-2024) & (US$ Million)
    Table 73. AMRI3 Recent Developments
    Table 74. Patheon Company Details
    Table 75. Patheon Business Overview
    Table 76. Patheon CMO & CDMO Product
    Table 77. Patheon Revenue in CMO & CDMO Business (2019-2024) & (US$ Million)
    Table 78. Patheon Recent Developments
    Table 79. Aenova Company Details
    Table 80. Aenova Business Overview
    Table 81. Aenova CMO & CDMO Product
    Table 82. Aenova Revenue in CMO & CDMO Business (2019-2024) & (US$ Million)
    Table 83. Aenova Recent Developments
    Table 84. Catalent Company Details
    Table 85. Catalent Business Overview
    Table 86. Catalent CMO & CDMO Product
    Table 87. Catalent Revenue in CMO & CDMO Business (2019-2024) & (US$ Million)
    Table 88. Catalent Recent Developments
    Table 89. Amatsigroup Company Details
    Table 90. Amatsigroup Business Overview
    Table 91. Amatsigroup CMO & CDMO Product
    Table 92. Amatsigroup Revenue in CMO & CDMO Business (2019-2024) & (US$ Million)
    Table 93. Amatsigroup Recent Developments
    Table 94. WuXi PharmaTech Company Details
    Table 95. WuXi PharmaTech Business Overview
    Table 96. WuXi PharmaTech CMO & CDMO Product
    Table 97. WuXi PharmaTech Revenue in CMO & CDMO Business (2019-2024) & (US$ Million)
    Table 98. WuXi PharmaTech Recent Developments
    Table 99. Strides Shasun Company Details
    Table 100. Strides Shasun Business Overview
    Table 101. Strides Shasun CMO & CDMO Product
    Table 102. Strides Shasun Revenue in CMO & CDMO Business (2019-2024) & (US$ Million)
    Table 103. Strides Shasun Recent Developments
    Table 104. Piramal Company Details
    Table 105. Piramal Business Overview
    Table 106. Piramal CMO & CDMO Product
    Table 107. Piramal Revenue in CMO & CDMO Business (2019-2024) & (US$ Million)
    Table 108. Piramal Recent Developments
    Table 109. Siegfried Company Details
    Table 110. Siegfried Business Overview
    Table 111. Siegfried CMO & CDMO Product
    Table 112. Siegfried Revenue in CMO & CDMO Business (2019-2024) & (US$ Million)
    Table 113. Siegfried Recent Developments
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global CMO & CDMO Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global CMO & CDMO Market Share by Type: 2023 VS 2030
    Figure 3. Development Features
    Figure 4. API production Features
    Figure 5. Formulation Features
    Figure 6. Global CMO & CDMO Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global CMO & CDMO Market Share by Application: 2023 VS 2030
    Figure 8. Pharmaceutical Industry Case Studies
    Figure 9. Biotechnology Case Studies
    Figure 10. Other Case Studies
    Figure 11. CMO & CDMO Report Years Considered
    Figure 12. Global CMO & CDMO Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global CMO & CDMO Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global CMO & CDMO Market Share by Region: 2023 VS 2030
    Figure 15. Global CMO & CDMO Market Share by Players in 2023
    Figure 16. Global Top CMO & CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CMO & CDMO as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by CMO & CDMO Revenue in 2023
    Figure 18. North America CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America CMO & CDMO Market Share by Type (2019-2030)
    Figure 20. North America CMO & CDMO Market Share by Application (2019-2030)
    Figure 21. North America CMO & CDMO Market Share by Country (2019-2030)
    Figure 22. United States CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe CMO & CDMO Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe CMO & CDMO Market Share by Type (2019-2030)
    Figure 26. Europe CMO & CDMO Market Share by Application (2019-2030)
    Figure 27. Europe CMO & CDMO Market Share by Country (2019-2030)
    Figure 28. Germany CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China CMO & CDMO Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China CMO & CDMO Market Share by Type (2019-2030)
    Figure 36. China CMO & CDMO Market Share by Application (2019-2030)
    Figure 37. Asia CMO & CDMO Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia CMO & CDMO Market Share by Type (2019-2030)
    Figure 39. Asia CMO & CDMO Market Share by Application (2019-2030)
    Figure 40. Asia CMO & CDMO Market Share by Region (2019-2030)
    Figure 41. Japan CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America CMO & CDMO Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America CMO & CDMO Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America CMO & CDMO Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America CMO & CDMO Market Share by Country (2019-2030)
    Figure 51. Brazil CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries CMO & CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Recipharm Revenue Growth Rate in CMO & CDMO Business (2019-2024)
    Figure 58. AMRI3 Revenue Growth Rate in CMO & CDMO Business (2019-2024)
    Figure 59. Patheon Revenue Growth Rate in CMO & CDMO Business (2019-2024)
    Figure 60. Aenova Revenue Growth Rate in CMO & CDMO Business (2019-2024)
    Figure 61. Catalent Revenue Growth Rate in CMO & CDMO Business (2019-2024)
    Figure 62. Amatsigroup Revenue Growth Rate in CMO & CDMO Business (2019-2024)
    Figure 63. WuXi PharmaTech Revenue Growth Rate in CMO & CDMO Business (2019-2024)
    Figure 64. Strides Shasun Revenue Growth Rate in CMO & CDMO Business (2019-2024)
    Figure 65. Piramal Revenue Growth Rate in CMO & CDMO Business (2019-2024)
    Figure 66. Siegfried Revenue Growth Rate in CMO & CDMO Business (2019-2024)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

RELATED REPORTS

Global Herbal Capsule Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22V13305
Fri May 23 00:00:00 UTC 2025

Add to Cart

Global PD-1 and PD-L1 Drug Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-39H13383
Fri May 23 00:00:00 UTC 2025

Add to Cart

Global NBL1 ELISA Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13T13366
Fri May 23 00:00:00 UTC 2025

Add to Cart

Global Dopamine Transporter Monoclonal Antibody Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O13370
Fri May 23 00:00:00 UTC 2025

Add to Cart